The Cost‐Effectiveness of a Multi‐Target Stool DNA‐Based Screening (COLOTECT), FIT, Colonoscopy and No Screening for Colorectal Cancer

The Cost‐Effectiveness of a Multi‐Target Stool DNA‐Based Screening (COLOTECT), FIT, Colonoscopy and No Screening for Colorectal Cancer

ABSTRACT Background Around 1.9 million new cases and 1 million deaths worldwide were attributed to colorectal cancer (CRC) in 2020. Aims The aims of this study are to assess the cost‐effectiveness of a multi‐target stool DNA‐based screening strategy, COLOTECT, compared to faecal immunochemical tests...

Full description

Saved in:
Bibliographic Details
Main Authors: Junjie Huang, Mingtao Chen, Victor C. W. Chan, Xianjing Liu, Chaoying Zhong, Jianli Lin, Junjie Hang, Claire Chenwen Zhong, Jinqiu Yuan, Martin C. S. Wong
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:Cancer Reports
Subjects:
colorectal cancer
cost‐effectiveness
multi‐target stool DNA
non‐invasive biomarker
screening
Online Access:https://doi.org/10.1002/cnr2.70176
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items